Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Céline Parmentier

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Neoplasia (New York, N.Y.)|July 2, 2009
Gemcitabine-based chemogene therapy for pancreatic cancer using Ad-dCK::UMK GDEPT and TS/RR siRNA strategiesSoukaina Réjiba, Christelle Bigand, Céline Parmentier, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2007
Telomerase transcriptional targeting of inducible Bax/TRAIL gene therapy improves gemcitabine treatment of pancreatic cancerSéverine Wack, Soukaina Rejiba, Céline Parmentier, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2019
Transcriptomic Analysis of Cholestatic Compounds In VitroCéline Parmentier, Philippe Couttet, Marianne Uteng, et al.
Toxicology and Applied Pharmacology|December 19, 2021
Evaluation of human relevance of Nicofluprole-induced rat thyroid disruptionCéline Parmentier, Audrey Baze, Meiggie Untrau, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 23, 2011
Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancerSoukaina Réjiba, L Harivardhan Reddy, Christelle Bigand, et al.
International Journal of Molecular Sciences|October 23, 2021
Primary Human Hepatocyte Spheroids as Tools to Study the Hepatotoxic Potential of Non-Pharmaceutical ChemicalsVânia Vilas-Boas, Eva Gijbels, Kaat Leroy, et al.
Toxicology Letters|June 19, 2018
Inter-individual differences in the susceptibility of primary human hepatocytes towards drug-induced cholestasis are compound and time dependentCéline Parmentier, Delilah F G Hendriks, Bruno Heyd, et al.
Archives of Toxicology|February 12, 2017
Evaluation of transcriptomic signature as a valuable tool to study drug-induced cholestasis in primary human hepatocytesCéline Parmentier, Philippe Couttet, Armin Wolf, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|December 30, 2014
In vitro kinetics of amiodarone and its major metabolite in two human liver cell models after acute and repeated treatmentsGiuliana Pomponio, Camille C Savary, Céline Parmentier, et al.
Tissue Engineering. Part C, Methods|August 14, 2018
Three-Dimensional Spheroid Primary Human Hepatocytes in Monoculture and Coculture with Nonparenchymal CellsAudrey Baze, Céline Parmentier, Delilah F G Hendriks, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Neoplasia (New York, N.Y.)|July 2, 2009
Gemcitabine-based chemogene therapy for pancreatic cancer using Ad-dCK::UMK GDEPT and TS/RR siRNA strategiesSoukaina Réjiba, Christelle Bigand, Céline Parmentier, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2007
Telomerase transcriptional targeting of inducible Bax/TRAIL gene therapy improves gemcitabine treatment of pancreatic cancerSéverine Wack, Soukaina Rejiba, Céline Parmentier, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2019
Transcriptomic Analysis of Cholestatic Compounds In VitroCéline Parmentier, Philippe Couttet, Marianne Uteng, et al.
Toxicology and Applied Pharmacology|December 19, 2021
Evaluation of human relevance of Nicofluprole-induced rat thyroid disruptionCéline Parmentier, Audrey Baze, Meiggie Untrau, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 23, 2011
Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancerSoukaina Réjiba, L Harivardhan Reddy, Christelle Bigand, et al.
International Journal of Molecular Sciences|October 23, 2021
Primary Human Hepatocyte Spheroids as Tools to Study the Hepatotoxic Potential of Non-Pharmaceutical ChemicalsVânia Vilas-Boas, Eva Gijbels, Kaat Leroy, et al.
Toxicology Letters|June 19, 2018
Inter-individual differences in the susceptibility of primary human hepatocytes towards drug-induced cholestasis are compound and time dependentCéline Parmentier, Delilah F G Hendriks, Bruno Heyd, et al.
Archives of Toxicology|February 12, 2017
Evaluation of transcriptomic signature as a valuable tool to study drug-induced cholestasis in primary human hepatocytesCéline Parmentier, Philippe Couttet, Armin Wolf, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|December 30, 2014
In vitro kinetics of amiodarone and its major metabolite in two human liver cell models after acute and repeated treatmentsGiuliana Pomponio, Camille C Savary, Céline Parmentier, et al.
Tissue Engineering. Part C, Methods|August 14, 2018
Three-Dimensional Spheroid Primary Human Hepatocytes in Monoculture and Coculture with Nonparenchymal CellsAudrey Baze, Céline Parmentier, Delilah F G Hendriks, et al.
Pageof 2